Inventor
BECK JAMES P
35 patents
⚠️ This page may combine multiple inventors who share the name “BECK JAMES P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UPJOHN CO
6 patentsUS7067507B2Jun 27, 2006
Macrocycles useful in the treatment of Alzheimer's disease
UPJOHN CO235 citations97
US7244725B2Jul 17, 2007
Acetyl 2-hydroxy-1, 3-diaminoalkanes
UPJOHN CO16 citations83
US6969709B2Nov 29, 2005
Macrocycles useful in the treatment of Alzheimer's disease
UPJOHN CO7 citations73
US6846813B2Jan 25, 2005
Compounds to treat alzheimer's disease
UPJOHN CO10 citations73
US7442691B2Oct 28, 2008
Macrocycles useful in the treatment of alzheimer's disease
UPJOHN CO0 citations51
US7262208B2Aug 28, 2007
Hydroxypropyl amides for the treatment of Alzheimer's disease
UPJOHN CO2 citations51
AMR TECHNOLOGY INC
5 patentsUS7541357B2Jun 2, 2009
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AMR TECHNOLOGY INC24 citations92
US7163949B1Jan 16, 2007
4-phenyl substituted tetrahydroisoquinolines and use thereof
AMR TECHNOLOGY INC26 citations92
US7419985B2Sep 2, 2008
4-Phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
AMR TECHNOLOGY INC23 citations90
US7309789B2Dec 18, 2007
4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
AMR TECHNOLOGY INC18 citations90
US7084152B2Aug 1, 2006
4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
AMR TECHNOLOGY INC41 citations90
ALBANY MOLECULAR RES INC
4 patentsUS6579885B2Jun 17, 2003
Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
ALBANY MOLECULAR RES INC50 citations94
US7612090B2Nov 3, 2009
Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
ALBANY MOLECULAR RES INC15 citations91
US9499531B2Nov 22, 2016
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC2 citations63
US9085531B2Jul 21, 2015
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ALBANY MOLECULAR RES INC0 citations52
ELAN PHARM INC
4 patentsUS7214715B2May 8, 2007
Compounds to treat Alzheimer's disease
ELAN PHARM INC18 citations83
US7456163B2Nov 25, 2008
Macrocycles useful in the treatment of alzheimer's disease
ELAN PHARM INC0 citations51
US7645780B2Jan 12, 2010
Acetyl 2-hydroxy-1, 3-diaminoalkanes
ELAN PHARM INC1 citations49
US7566730B2Jul 28, 2009
Substituted aminoethers for the treatment of Alzheimer's disease
ELAN PHARM INC0 citations40
DU PONT PHARM CO
3 patentsUS6245769B1Jun 12, 2001
Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
DU PONT PHARM CO25 citations92
US6174912B1Jan 16, 2001
Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonists
DU PONT PHARM CO21 citations84
US6103737AAug 15, 2000
Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists
DU PONT PHARM CO15 citations72
MOLINO BRUCE F
3 patentsUS8236796B2Aug 7, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8227486B2Jul 24, 2012
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F10 citations83
US8741901B2Jun 3, 2014
Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MOLINO BRUCE F0 citations51